Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Industry News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

September 12, 2019

News Industry News

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

July 01, 2019

News Industry News

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

April 26, 2019

News Industry News

Mitralign announces enrollment of first European subject in Transcatheter Tricuspid Repair Study enrolled in SCOUT II Study with Trialign™ System for Transcatheter Tricuspid Repair

June 16, 2017

News Industry News

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

December 01, 2016

News Industry News

Mitralign Completes Enrollment in First Phase of US Early Feasibility Study on Tricuspid Repair

July 13, 2016

News Industry News

Mitralign Percutaneous Annuloplasty System Earns CE Mark Approval for Functional Mitral Regurgitation

February 21, 2016

News Industry News

Mitralign to Provide Update on Transcatheter Tricuspid Repair at TCT 2015

October 12, 2015

News Industry News

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

September 14, 2015

News Industry News

Mitralign Receives FDA Approval for Percutaneous Tricuspid Repair Early Feasibility Study

August 31, 2015

News Industry News

Cardiac Dimensions launches clinical trial for Carillon mitral valve device

June 25, 2015

News Industry News

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

June 04, 2013

News Industry News

Cardiac Dimensions Announces Presentation of Two-Year Efficacy Data From TITAN Clinical Trial

November 06, 2011

Advertisement

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

Mitralign announces enrollment of first European subject in Transcatheter Tricuspid Repair Study enrolled in SCOUT II Study with Trialign™ System for Transcatheter Tricuspid Repair

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

Mitralign Completes Enrollment in First Phase of US Early Feasibility Study on Tricuspid Repair

Mitralign Percutaneous Annuloplasty System Earns CE Mark Approval for Functional Mitral Regurgitation

Mitralign to Provide Update on Transcatheter Tricuspid Repair at TCT 2015

Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair

Mitralign Receives FDA Approval for Percutaneous Tricuspid Repair Early Feasibility Study

Cardiac Dimensions launches clinical trial for Carillon mitral valve device

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

Cardiac Dimensions Announces Presentation of Two-Year Efficacy Data From TITAN Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content